Article info
Electronic pages
Topical dexamethasone for recurrent aphthous ulceration reduces pain and size and increases healing with no significant adverse events
- Correspondence to: Rachel Cowie
WHO Collaborating Centre for Oral Health-General Health, Bristol Dental Hospital, Lower Maudlin St, Bristol, Avon BS1 2LY, UK; Rachel.Cowie{at}UHBristol.nhs.uk
Citation
Topical dexamethasone for recurrent aphthous ulceration reduces pain and size and increases healing with no significant adverse events
Publication history
- First published May 14, 2012.
Online issue publication
October 25, 2017
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions